Register Now
Youtube Linkedin Facebook

Financing, business development, and technology scouting

dxpx general logo white text

Unlock growth opportunities through high-powered networking in Diagnostics, Digital Health,
Precision Medicine, and Life Sciences Tools.

DxPx Europe `26

Reception: Thursday, February 5th, 2026
Partnering Day & 42PLUS1: February 6th, 2026

Munich, Germany

Venue: Leonardo Royal Munich

Moosacher Straße 90 | 80809 München | Germany

Register for DxPx Europe `26
0

Exhibitors

0

One-on-one meeting areas

0

Investors

0

Speakers

0

Panel discussions

0 +

Countries

0

Sq. Ft.
Conference venue

Register Now For DxPx Europe `26

Join DxPx Europe ’26 to discuss M&A, licensing, and financing opportunities, meet old acquaintances and make new international contacts.

Meet investors and industry partners who share your love for Diagnostics, Digital Health, Precision Medicine & Life Science Tools. 

  • 500+ participants with 100+ VC, corporate VC, and other investors expected: All sharing your interest in life science outside therapeutics and biotech
  • 20 Exhibitors: Selected innovations featured at our Startup City
  • 4 Panels: Featuring industry experts and investors sharing their knowledge
  • 1 Pitch award: 8 companies that are carefully selected by over 30 VCs prior to the event will present their business and compete for funding of up to 2,000,000 USD as convertible loans

DxPx is a clear win for us. We look forward to participating again as a partner and judge for the 42PLUS1 Pitch Award.

qiagen logo sponsordxpx eu conference

Sebastian Swienty

Senior Director, Corporate Business Development Licensing

DxPx is one the premier conferences where diagnostics innovation meets investment opportunity. Grateful to join such a visionary community and explore paths to advance GLX Analytix’s mission to personalize medicine.

Brian DellaValle

CEO & Founder

Register for DxPx Europe `26

Meet.

Set up your personal itinerary by pre-scheduling one-to-one meetings with growth companies, investors and decision makers from Diagnostic, Digital Health, Precision Med. and Life Science Tool companies.

Discuss.

Learn from active family offices, venture capitals, private equity, strategic investors and industry experts who share their experiences and strategies.

Exhibit.

Promote your company to industry executives and showcase products at your booth to get the most out of your DxPx attendance. The company presentations and contacts will also be made available digitally.

Pitch.

Submit a pitch that will be reviewed by our executive jury. The best applicants will be invited to pitch their business and compete for $2,000,000 funding at our 42PLUS1 Pitch Award.

“Winning a 42PLUS1 funding of $500,000 and joining the DxPx ecosystem has been a game-changer for FluidAI. This investment has not only accelerated our growth but also empowered us to scale our innovative AI solutions while forging strategic connections with industry leaders who share our vision for revolutionizing healthcare.”

Youssef Helwa

CEO and cofounder

fluidai
  • Meet global leaders, investors & innovative growth companies from 30+ countries
  • Explore financing, licensing and M&A partnerships in pre-scheduled one-to-one meetings
  • Exhibit and promote your business with an own booth – be quick, limited spaces available

Highlights from DxPx EU '25

Meet executives, investors & peers who share your passion.

Startups: Find your investor at DxPx for a successful future for your company.

  • Meet 150+ investors
  • Learn from industry and financing experts
  • Connect with other entrepreneurs

As an industry partner, don’t waste time and make each meeting count.

  • Effective technology & business scouting as all meetings are pre-selected
  • Private, undisturbed discussions in dedicated meeting cubicles
  • Access to investor, private equity, and growth stage investor panels
  • Marginal additional cost as DxPx is co-hosted with leading industry conferences
  • Recognition as innovation leader when joining DxPx & 42PLUS1 as partner

Investors can expand their network and meet old & new acquaintances.

  • Find members for syndicates for your portfolio companies
  • Meet with strategics and investment banks to facilitate exits
  • Gain free access to the 42PLUS1 applicants and learn about new technologies
  • One-on-one meetings with founders to get a firsthand impression
  • Free access in exchange for providing feedback to only 5 pitch applicants prior to DxPx
Register for DxPx Europe `26

Download the Introduction to DxPx

After you have filled out the form, the PDF download will start automatically.

    First name

    Last name

    E-mail

    Several hundred investors from the EU, U.S. and the rest of the world, with interest in diagnostics, digital health, precision medicine and life science tools.

    dxpx investors
    View more

    Don't miss our investor conferences & early-stage investing events:

    dxpx us adlm logos
    DxPx US

    DxPx Industry & Investor Conference US:
    4 Days In-Person

    July 29 - Aug. 1, 2024
    Chicago, IL
    In the ADLM

    Stay up to date and sign up for our latest news:

    Next: DxPx U.S. 2025
    • 3 Days In-Person
    • July 29 - 31, 2025
    • McCormick Place
      Convention Center
      Chicago, Illinois, USA
    Next: DxPx EU 2026
    • 2 Days In-Person
    • Reception: February 5, 2026
      Partnering Day & 42PLUS1:
      February 6, 2026
    • Munich, Germany
    Download Brochure
    DxPx media
    Useful links

    © Copyright DxPx 2025. All Rights Reserved.

    Youtube Linkedin Facebook

    Oliver Dick

    Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

    Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

    Experience

    Christoph Brandenberger

    Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

    A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

    Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

    Experience

    John Riddle

    John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

    John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

    Experience

    Dr. Mirko Stange

    Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

    In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

    Experience

    FName LName

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

    Experience